--- title: "SRS Finance Ltd (536799) — Share Price, Financials & Analysis" symbol: "536799" company: "SRS Finance Ltd" canonical: "https://tapetide.com/stocks/536799" isin: "INE002J01027" bse_code: "536799" sector: "Financial Services" industry: "Finance" generated_at: "2026-09-13T18:57:46.680Z" --- # SRS Finance Ltd (536799) Canonical page: https://tapetide.com/stocks/536799 ## Company - **BSE Code:** 536799 - **ISIN:** INE002J01027 - **Sector:** Financial Services - **Industry:** Finance - **Macro Sector:** Financial Services - **Stock Type:** EQUITY - **Listed Since:** 2013-11-18 - **Face Value:** ₹1 - **F&O Eligible:** No - **Website:** srsparivar.com ## About SRS Finance Limited is engaged in the business of non-banking financial institution. ## Latest Price ## Key Insights ### Strengths - Stock is trading at 0.18 times its book value ### Weaknesses - Company has low interest coverage ratio. - The company has delivered a poor sales growth of -7.46% over past five years. - Company has a low return on equity of -1.51% over last 3 years. - Company has high debtors of 159 days. - Working capital days have increased from 690 days to 1,228 days ## Growth Rates | Metric | 1Y | 3Y | 5Y | | --- | --- | --- | --- | | revenue growth | -117% | -23% | -7% | ## Financial Statements ### Quarterly Results All figures in ₹ crore unless the row name says otherwise. | Item | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Revenue | 44 | 6 | 16 | 17 | 13 | 15 | 6 | 5 | -7 | 1 | 0 | 0 | | Expenses | 40 | 1 | 9 | 12 | 13 | 9 | 1 | 2 | 9 | 3 | 2 | 7 | | Financing Profit | 1 | 3 | 4 | 2 | -3 | 2 | 1 | 1 | -19 | -3 | -2 | -16 | | Financing Margin % | 3 | 40 | 23 | 13 | -23 | 15 | 13 | 28 | 266 | -299 | 4180 | 4203 | | Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | Interest | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 1 | 3 | 1 | 0 | 9 | | Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | Profit before tax | 1 | 3 | 4 | 2 | -3 | 2 | 1 | 1 | -19 | -3 | -2 | -16 | | Tax % | 43 | 26 | 36 | 37 | -28 | 26 | 65 | 27 | -4 | 0 | 0 | 0 | | Net Profit | 1 | 2 | 2 | 1 | -2 | 2 | 0 | 1 | -18 | -3 | -2 | -16 | | EPS in Rs | 0.01 | 0.02 | 0.02 | 0.01 | -0.02 | 0.02 | 0 | 0.01 | -0.18 | -0.03 | -0.02 | -0.17 | ### Profit & Loss All figures in ₹ crore unless the row name says otherwise. | Item | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | TTM | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Revenue | 62 | 76 | 37 | 27 | 14 | 39 | 76 | 53 | 18 | -6 | | Expenses | 61 | 73 | 33 | 19 | 20 | 21 | 52 | 35 | 21 | 20 | | Financing Profit | 0 | 1 | 1 | 1 | -12 | 7 | 10 | 5 | -14 | -40 | | Financing Margin % | 0 | 2 | 4 | 4 | -87 | 19 | 13 | 10 | -80 | 618 | | Other Income | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | Interest | 1 | 2 | 3 | 6 | 6 | 11 | 15 | 13 | 12 | 13 | | Depreciation | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | Profit before tax | 0 | 1 | 1 | 1 | -12 | 7 | 10 | 5 | -14 | -40 | | Tax % | 40 | 51 | 40 | 28 | -31 | 30 | 33 | 36 | 5 | — | | Net Profit | 0 | 1 | 1 | 1 | -8 | 5 | 6 | 3 | -15 | -39 | | EPS in Rs | — | — | — | — | -0.09 | 0.05 | 0.06 | 0.03 | -0.15 | -0.4 | | Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | ### Balance Sheet All figures in ₹ crore unless the row name says otherwise. | Item | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Equity Capital | 3 | 3 | 98 | 98 | 98 | 98 | 98 | 98 | 98 | 98 | | Reserves | 0 | 0 | 17 | 18 | 19 | 10 | 16 | 22 | 25 | 10 | | Borrowing | 1 | 4 | 22 | 25 | 38 | 49 | 94 | 85 | 114 | 114 | | Other Liabilities | 1 | 92 | 6 | 0 | 0 | 0 | 2 | 2 | 20 | 16 | | Total Liabilities | 5 | 100 | 144 | 142 | 155 | 158 | 210 | 208 | 257 | 238 | | Fixed Assets | 1 | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | | CWIP | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | Investments | 0 | 64 | 24 | 63 | 78 | 28 | 24 | 18 | 20 | 47 | | Other Assets | 3 | 32 | 118 | 78 | 75 | 128 | 185 | 189 | 237 | 191 | | Total Assets | 5 | 100 | 144 | 142 | 155 | 158 | 210 | 208 | 257 | 238 | ### Cash Flow All figures in ₹ crore unless the row name says otherwise. | Item | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Cash from Operating Activity | -1 | 31 | -90 | 32 | 2 | -55 | -39 | -39 | -17 | 39 | | Cash from Investing Activity | 0 | 25 | 41 | -32 | -8 | 50 | 5 | 5 | -2 | -28 | | Cash from Financing Activity | 1 | -56 | 49 | 0 | 6 | 5 | 35 | 35 | 16 | -11 | | Net Cash Flow | 0 | 0 | 1 | -1 | 0 | 0 | 1 | 1 | -2 | 0 | | Free Cash Flow | -1 | 34 | -90 | 32 | 1 | -55 | -39 | -39 | -17 | 39 | | CFO/OP | -357 | 4644 | -2972 | 751 | 33 | 928 | -216 | -160 | -83 | -1366 | ### Ratios | Item | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | ROE % | 8 | 4 | 1 | 1 | 1 | -7 | 5 | 5 | 3 | -13 | ## Shareholding Pattern ### annual | Category | Mar 2017 | Mar 2018 | Jun 2018 | | --- | --- | --- | --- | | Promoters | 69.16% | 69.16% | 69.16% | | Public | 30.84% | 30.84% | 30.84% | | No. of Shareholders | 1192 | 1357 | 1429 | ### Quarterly | Category | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Promoters | 69.16% | 69.16% | 69.16% | 69.16% | 69.16% | 69.16% | 69.16% | 69.16% | 69.16% | | Public | 30.84% | 30.84% | 30.84% | 30.84% | 30.84% | 30.84% | 30.84% | 30.84% | 30.84% | | No. of Shareholders | 938 | 1144 | 1175 | 1192 | 1171 | 1190 | 1207 | 1357 | 1429 | ## Filings & Documents ### Other Documents | Date | Document | | --- | --- | | 28 January 2026 - Reconciliation of Share Capital Audit for quarter ended Dec 31, 2025; issued capital 11,700,000 shares. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 28 January 2026 - Reconciliation of Share Capital Audit for quarter ended Dec 31, 2025; issued capital 11,700,000 shares.](https://nsearchives.nseindia.com/corporate/MEDICAMENORGANICS_28012026160058_Reco_report_medicamen_31122025.pdf) | | 28 January 2026 - Published Postal Ballot and e-voting notice in Financial Express and Jansatta on Jan 28, 2026. | [Copy of Newspaper Publication 28 January 2026 - Published Postal Ballot and e-voting notice in Financial Express and Jansatta on Jan 28, 2026.](https://nsearchives.nseindia.com/corporate/MEDICAMENORGANICS_28012026143719_Covering_Letter_newspaper.pdf) | | 27 January 2026 - Postal ballot: reallocate Rs162.44L IPO proceeds to working capital; approve excess director remuneration; reappoint Ashutosh Gupta April 30,2026. | [Updates 27 January 2026 - Postal ballot: reallocate Rs162.44L IPO proceeds to working capital; approve excess director remuneration; reappoint Ashutosh Gupta April 30,2026.](https://nsearchives.nseindia.com/corporate/MEDICAMENORGANICS_27012026192755_Notice_postal_ballot.pdf) | | 27 February 2026 - Postal ballot approved Feb 27, 2026: IPO objects variation; remuneration excess; reappointment of Ashutosh Gupta. | [Shareholders meeting 27 February 2026 - Postal ballot approved Feb 27, 2026: IPO objects variation; remuneration excess; reappointment of Ashutosh Gupta.](https://nsearchives.nseindia.com/corporate/MEDICAMENORGANICS_27022026170734_Postal_Ballot_Voting_Results.pdf) | | 24 January 2026 - Jan 24: 4,65,910 warrants converted (Rs2,24,99,959); IPO object change; MD reappointed Apr30,2026–Apr29,2031. | [Outcome of Board Meeting 24 January 2026 - Jan 24: 4,65,910 warrants converted (Rs2,24,99,959); IPO object change; MD reappointed Apr30,2026–Apr29,2031.](https://nsearchives.nseindia.com/corporate/MEDICAMENORGANICS_24012026191735_Outcome_of_BM_final.pdf) | | 14 January 2026 - Certificate under Regulation 74(5) confirming dematerialisation details for quarter ended Dec 31, 2025. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 14 January 2026 - Certificate under Regulation 74(5) confirming dematerialisation details for quarter ended Dec 31, 2025.](https://nsearchives.nseindia.com/corporate/MEDICAMENORGANICS_14012026182816_F_Regulation_74_5__Q3_202526.pdf) | | — | [Announcement under Regulation 30 (LODR)-Change in Registered Office Address 4 Aug 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a7b6c89-78f2-4d5d-b061-62bd1b8c10be.pdf) | | — | [Announcement under Regulation 30 (LODR)-Change in Registered Office Address 4 Aug 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/8/0a7b6c89-78f2-4d5d-b061-62bd1b8c10be.pdf) | | — | [Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO) 31 May 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=273db95f-3499-4a38-b0f1-3ef14b78c516.pdf) | | — | [Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO) 31 May 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/5/273db95f-3499-4a38-b0f1-3ef14b78c516.pdf) | ### Earnings Call Documents | Date | Document | | --- | --- | | Oct 2024 | [Concall - Oct 2024](https://nsearchives.nseindia.com/corporate/MEDIORG_22102024190822_Regulation30InvestorPresentation.pdf) | | Nov 2024 | [Concall - Nov 2024](https://nsearchives.nseindia.com/corporate/MEDIORG_25112024203941_SubmissionofTranscriptH1FY25.pdf) | | Jun 2025 | [Concall - Jun 2025](https://nsearchives.nseindia.com/corporate/MEDICAMENORGANICS_10062025173415_Final_Intimation_10062025_Transcript.pdf) | ### Annual Reports | Date | Document | | --- | --- | | from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_28196_MEDIORG_2024_2025_A_37882764_02092025185839.pdf) | | from nse | [Financial Year 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_26302_MEDIORG_2023_2024_0310202414145.pdf) | | from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/536799/5367990317.pdf) | | from bse | [Annual Report 2016 from bse](https://www.bseindia.com/bseplus/AnnualReport/536799/5367990316.pdf) | | from bse | [Annual Report 2015 from bse](https://www.bseindia.com/bseplus/AnnualReport/536799/5367990315.pdf) | | from bse | [Annual Report 2014 from bse](https://www.bseindia.com/bseplus/AnnualReport/536799/5367990314.pdf) | --- Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:57:46.680Z.